⌘K

Home/Filings/4/0001677036-25-000004

4//SEC Filing

Lind Kevin Robert 4

Accession 0001677036-25-000004

CIK 0001534120other

View on SEC.gov Company Profile

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 4:23 PM ET

Size

5.5 KB

Accession

0001677036-25-000004

Insider Transaction Report

Form 4

Period: 2025-10-01

Avalo Therapeutics, Inc.AVTX

Lind Kevin Robert

Director

Transactions

Award
Stock Option (Right to Buy)
2025-10-01+40,200→ 40,200 total
Exercise: $12.96Exp: 2035-10-01→ Common Stock (40,200 underlying)

Footnotes (1)

[F1]The stock option vests in three substantially equal installments on the first, second and third anniversary of the date of grant, subject to the Eligible Director's continued service on each such vesting date.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Avalo Therapeutics, Inc.

CIK 0001534120

Entity typeother

Related Parties

1

filerCIK 0001677036

Filing Metadata

Form type: 4
Filed: Oct 1, 8:00 PM ET
Accepted: Oct 2, 4:23 PM ET
Size: 5.5 KB

View on SEC.gov